Casdin Capital
-
Philadelphia-based Century Therapeutics Acquires Boston Biotechnology Firm, Clade Therapeutics
Philadelphia-based Century Therapeutics recently raised $60 million in a private placement of almost 16 million shares of its stock and acquired Boston-based Clade Therapeutics, writes…
Founding Partners
Advertisement
Affiliate Partners
